
Overview
Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs.
Dr. Berkenstock is highly rated in 10 conditions, according to our data. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.
Her clinical research consists of co-authoring 76 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, Baltimore, MD 21287
4692 Millennium Drive, Belcamp, MD 21017
Additional Areas of Focus
Dr. Berkenstock has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
The Johns Hopkins Hospital
Jennifer Thorne, M.D., Ph.D., is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, where she is also chief of the Division of Ocular Immunology. Dr. Thorne holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. An internationally recognized ophthalmologist, Dr. Thorne is an expert in the evaluation and management of patients with uveitis and other related immune-mediated disorders. Dr. Thorne also directs the Mucous Membrane Pemphigoid clinic, a multi-disciplinary specialty clinic designed to evaluate and treat patients with conjunctival diseases. Dr. Thorne's research interests include white dot syndromes including birdshot chorioretinitis, multifocal choroiditis and punctate inner choroiditis. She also studies juvenile idiopathic arthritis-related uveitis and treatment outcomes of immunosuppressive drug therapy. Dr. Thorne received her M.D. degree from the University of Virginia and completed her ophthalmology residency at the University of Pennsylvania's Scheie Eye Institute. She completed her uveitis fellowship at Wilmer and completed her Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Thorne is highly rated in 17 conditions, according to our data. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, Cataract Removal, and Vitrectomy.
The Johns Hopkins Hospital
Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is highly rated in 14 conditions, according to our data. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.
Frequently Asked Questions about Dr. Meghan Berkenstock
How do I make an appointment with Dr. Meghan Berkenstock?
You can book an appointment with Dr. Meghan Berkenstock by calling their office at 410-955-5080. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Meghan Berkenstock a top-rated expert for Scleritis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meghan Berkenstock is classified as an Elite expert for Scleritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Meghan Berkenstock specialize in?
While Dr. Meghan Berkenstock is a Ophthalmology, they have specific expertise in Scleritis, Episcleritis, and Uveitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Meghan Berkenstock participate in research or clinical trials?
Yes. Dr. Meghan Berkenstock has published 76 articles and abstracts on conditions like Scleritis. You can view a list of Dr. Meghan Berkenstock's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Meghan Berkenstock accept my insurance?
Dr. Meghan Berkenstock accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-955-5080 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EpiscleritisDr. Berkenstock isElite. Learn about Episcleritis.
- ScleritisDr. Berkenstock isElite. Learn about Scleritis.
- UveitisDr. Berkenstock isElite. Learn about Uveitis.
- Advanced
- CataractDr. Berkenstock isAdvanced. Learn about Cataract.
- Cogan's SyndromeDr. Berkenstock isAdvanced. Learn about Cogan's Syndrome.
- EndophthalmitisDr. Berkenstock isAdvanced. Learn about Endophthalmitis.
- Interstitial KeratitisDr. Berkenstock isAdvanced. Learn about Interstitial Keratitis.
- NeuroretinitisDr. Berkenstock isAdvanced. Learn about Neuroretinitis.
- Periorbital CellulitisDr. Berkenstock isAdvanced. Learn about Periorbital Cellulitis.
- Experienced
- Age-Related Macular Degeneration (ARMD)Dr. Berkenstock isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- BlepharitisDr. Berkenstock isExperienced. Learn about Blepharitis.
- Brown SyndromeDr. Berkenstock isExperienced. Learn about Brown Syndrome.
- Cataract RemovalDr. Berkenstock isExperienced. Learn about Cataract Removal.
- Cicatricial PemphigoidDr. Berkenstock isExperienced. Learn about Cicatricial Pemphigoid.
- Conjunctivitis (Pink Eye)Dr. Berkenstock isExperienced. Learn about Conjunctivitis (Pink Eye).


